Biologically active natural products are often used as starting points and potential sources for drug discovery, along with being critical tools for learning about biologically important processes. Unfortunately, natural products can generally only be isolated in very minute quantities from natural sources, so supplies with which to carry out a full physiological and biological assessment are often extremely scarce. Even when promising leads or potential drugs are identified among these natural products, the lack of availability and scalability repre sents a formidable barrier to their further development and evaluation in drug discovery. Fortunately, chemical synthesis has the potential to solve the supply problem by providing larger quantities of natural products and their analogues in a more efficient and scalable manner, thus enabling a better understanding of their biological action and biogenetic syn thesis. Furthermore, chemical manipulation presents oppor tunities for modifying the structure of natural products, with the ultimate aim of improving their activity or physicochemi cal/biological properties. Shizukaols A and E, two dimeric lindenanetype ter penes, were isolated from Chloranthus japonicas. Both possess a common heptacyclic framework containing more than 10 contiguous stereocenters with potential biological activities, which has attracted a considerable amount of interest from synthetic chemists. However, only one total synthesis of two dimeric members, shizukaol D and sarcandrolide J, was re ported by Professor Bo Liu and coworkers in 2017. Recently, Professor XiaoShui Peng from The Chinese University of Hong Kong, together with Dr. Bencan Tang from the University of Nottingham Ningbo China (P. R. of China), have reported the total syntheses of shizukaols A and E via a biomimetic syn thetic approach. Among the research priorities of the authors are, in fact, the design and accomplishment of a "bioinspired" total synthesis of structurally complex and biologically signi ficant natural products, and a better understanding of their biological action and biogenetic synthetic approach. This pro ject was initiated in 2010, when Dr. YinSuo Lu enrolled as a PhD student in the group of Professor Henry N. C. Wong at The Chinese University of Hong Kong (P. R. of China). Professor Peng explained: "In the early stage of his PhD studies, Dr. Lu achieved quite exciting preliminary results on the generation of an endotype core for shizukaol family members (Org. Lett. 2011 , 13, 2940 -2943 and Org. Lett. 2016 .
Based on these initial studies, Dr. Lu then achieved the crucial endocyclization product 5 through Diels-Alder reaction be tween diene 3 and dienophile 4 (Scheme 1). However, despite considerable experimentation, the conversion of the hydroxyl group of endocyclization product 5 into the carbonyl group in 6 could not be achieved." Nat. Commun. 2018, 9, 4040 
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In 2013, Dr. JianLi Wu joined this shizukaol project after the first target molecule, bolivianine, was synthesized by Professor Bo Liu of Sichuan University (P. R. of China), and he started investigating the endoselectivity of the Diels-Alder reaction and the improvement of synthetic efficiency in latestage functionalization. "Dr. Wu's investigation proved that the latestage conversion of the epoxy unit (Schemes 2 and 3) into the hydroxy keto ester unit of shizukaols A (1) and E (2), a common framework of the dimeric family members, was a more stepeconomic strategy for total synthesis. Thus, according to the structural features of the shizukaol family, Dr. Wu synthesized more suitable precursors 7, 8, and 13, being at least biogenetically much closer to intermediates suitable for further transformations through either a highly Zselective olefination of α-siloxy ketone with ynolate anions or an in tramolecular Horner-Wadsworth-Emmons olefination from commercially available Wieland-Miescher ketone," explained Professor Peng.
He continued: "As expected, the Diels-Alder reaction be tween 7 and 8, 8 and 13, respectively, worked well to afford the desired products (9, 14) with endo selectivity. However, efforts to invert the secondary α-hydroxy group in 11 or 15 were unsuccessful, probably due to the fact that the key hydroxy group at C9 was sterically hindered." The authors found that even the corresponding mesylate and triflate, which were easily epimerized, did not give positive results when treated with alkaline reagents such as DBU and KNO 2 . Therefore, oxid ation of alcohols 11 or 15 with Dess-Martin periodinane, re spectively, led to diones 12 and 16. Treatment of dione 12 with Zn(BH 4 ) 2 eventually gave the synthetic shizu kaol E (2) with a C9 β-hydroxy group, together with recyclable compound 11 in 92% yield with an α/β ratio of 2.8:1. Simil-Scheme 2 Total synthesis of shizukaol E (2); BHT = butylated hydroxytoluene, DMP = Dess-Martin periodinane, DMAP = 4-dimethylaminopyridine Literature Coverage Synform A20 arly, oxidation of 15 with Dess-Martin periodinane, followed by reduction of dione 16 with Zn(BH 4 ) 2 , eventually achieved shizukaol A (1) and alcohol 15 in 95% yield with an α/β ratio of 4.6:1. "Presum ably, the stereoselectivity of these reduc tions results from coordination between Zn(BH 4 ) 2 and the two carbonyl groups at C8 and C9 in diones 12 and 16. The relevant DFT calculations of the reduction of diones 12 and 16 with Zn(BH 4 ) 2 , performed by Dr. Bencan Tang, supported the observ ed stereoselectivity," said Professor Peng.
"In summary, the first total syntheses of shizukaols A (1) and E (2) were accomplished from commercially available Wieland-Miescher ketone in 0.1% overall yield over 24 steps and 0.15% overall yield over 28 steps in the longest linear se quences, respectively, involving a modified biomimetic Diels-Alder reaction and a biogenetic transformation of an epoxy unit to the common hydroxy keto ester species of the shizu kaol family," remarked Professor Peng. He continued: "This synthetic approach should open up a practical avenue for the total syntheses of the intriguing chloranthaceae family mem bers, and should facilitate as well the understanding of their relevant biological action in nature." Professor Peng concluded: "Last but not least, we would like to express our sincere gratitude to Professor Henry N. C.
Wong for his invaluable comments, which effectively helped us in achieving our synthetic goals, as well as for his great con tribution to the development of organic chemistry in China, on the occasion of his retirement from the Chinese University of Hong Kong after a career spanning over 35 years." 
INTERVIEW SYNFORM What is the focus of your current research activity?
Dr. J. Cornella The main focus of our research group is the development of rapid, practical and efficient methodologies for organic synthesis based on sustainable and cheap catal ysts, towards more sustainable chemical processes. In addi tion to efficiency and practicality, we are highly interested in discover ing new reactivity with the aim of unveiling novel transformations. More specifically, our group's interests are in the fundamental understanding and application of catal ytic processes and the development of simple reagents for or ganic synthesis. We believe that these two approaches have enorm ous potential with potential impact across the chemical sciences.
SYNFORM When did you get interested in synthesis?
Dr. J. Cornella I was first fascinated by synthesis in my un dergraduate courses at the Universitat de Barcelona, where I undertook the class "Síntesi Orgànica" with Prof. Albert Moyano. There, I discovered the beauty and fun of construct ing molecules and the plethora of possibilities for connecting and disconnecting bonds. Then, during my PhD and postdoc I learned how metals and catalysis can influence such discon nections, ultimately leading to extremely straightforward me thodologies. I was fascinated by the idea of using transition metals to dramatically shorten a synthesis that required se veral steps and a tremendous amount of effort, time and re sources. With this idea in mind, we are trying to add another variable to the equation: sustainability. In addition to stream lining synthesis, we are also attempting to provide sustainable approaches to these processes. In our laboratory, this implies the design of simple and readily available reagents or earth abundant metals as catalysts. In spring 2017, he was appointed as a Max Planck Group Leader in the Department of Organometallic Chemistry at the Max-Planck-Institut für Kohlenforschung in Mülheim an der Ruhr (Germany). He has been a Max Planck Research Group Leader (MPRGL) since the summer of 2017 at the same Institute, where he leads the Laboratory for Sustainable Homogeneous Catalysis, and was the recipient of the Thieme Chemistry Journals Award in 2017.
Dr. Josep (Pep) Cornella
Dr. J. Cornella Organic synthesis is truly vivid and alive. More specifically, homogeneous catalysis has become an in dispensable tool for organic synthesis. New methodologies to assemble molecular entities appear every day from re searchers around the world at an incredible pace. Thousands of methods are published every year, thus highlighting the richness and wide interest in this area. However, it seems that these fast-growing and large number of efficient and available methods do not translate when looking at applications in industrial contexts. A recent report 1 from medicinal chemists revealed that industry relies mainly on a small and specific set of reactions to synthesize their libraries of compounds. Although many factors can contribute to this, a determining factor is that the methods of choice (namely Suzuki cross coupling, amide bond formation, enantioselective hydrogen ation, etc.) are those which are simple, robust, scalable and reliable, especially when applied in complex synthetic con texts. In this regard, our research group places particular em phasis on covering the largest chemical space possible when develop ing new strategies (presence of a large variety of hete rocycles and sensitive functional groups) to be able to achieve the maximum translational potential possible.
SYNFORM Your research group is active in the area of catalysis applied to organic synthesis. Could you tell us more about your research and its aims?
Dr. J. Cornella In particular, we are interested in developing methodologies based on cheap and abundant Ni salts for the decoration of heterocycles, which are of major importance in pharmaceutical and agrochemical settings. We have develop ed a methodology for the functionalization of C-F bonds with alkyl Grignard reagents in a regioselective fashion to con struct new C-C bonds. 2 In addition to the activation of challenging and strong C-F bonds, we have identified a feature in the ligand (Thorpe-Ingold effect) that minimizes the formation of the commonly obtained by-products through β-hydride elimination/insertion events. This allows a rapid construction of nonplanar structures which are of great interest to medi cinal chemists to design and modify protein-drug interaction sites (Scheme 1).
Another area we are interested in is the development of practical reagents for organic synthesis. In this regard, we have recently developed a pyrylium reagent (PyryBF 4 ) which is capable of targeting amino groups C(sp 2 )-NH 2 , which are pre valent in a wide variety of chemical compounds. The reagent reacts preferentially with these functionalities, thus priming them for a simple and robust nucleophilic aromatic substitu tion (S N Ar). 3 Prior to our work, such reactivity was rather limit ed to the use of polyalkylated amines or diazo compounds, which are either explosive or unselective. The protocol devel oped by our group proceeds with extreme chemoselectivity and this permits the modification of C(sp 2 )-NH 2 bonds in late stage functionalization contexts as demons trated by the suc cessful modification of densely function alized molecules such as ibrutinib (anticancer), prazosine (antianxiety) and adeno sine (DNAbuilding material) (Scheme 2).
Another research line we are currently exploring is the study of the chemistry of lowvalent elements. For example, we are interested in highly reduced species of Ni and their capabilities as catalysts. While the high oxidation states of A23 Scheme 1 Ni-catalyzed branch-selective alkylation of C-F bonds
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Ni -Ni(IV) to Ni(0) -are well-known in the literature, little is known about the highly reduced species of Ni in the context of cross-coupling. In traditional cross-couplings the electron density is provided by the ancillary ligand: we wondered what would happen if this process is reversed, and the electron dens ity is mainly supplied by the metal center. Inspired by the seminal work from Jonas and Pörschke in the 1970s at MPI Kohlenforschung, we were able to identify a highly re duced Ni-Li-olefin complex [formally a Ni(-II)], which is cap able of catalyzing Kumada-Corriu cross-couplings at cryogenic temperatures. 4 The unprecedented activity of this Ni(-II) complex at low temperatures allowed the coupling of moieties bearing sensitive functional groups, which would react with the Grignard at higher temperatures, such as esters and nitriles. Although preliminary studies point towards the possibility of a low-valent catalytic cycle involving Ni(-II) species to forge C-C bonds, details on a full mechanistic picture are still under investigation (Scheme 3).
Nitrogen atoms are ubiquitous in pharmaceuticals, natural products, materials, and commodity chemicals. The simplest amine -ammonia -is central to life since its use as fertilizer quite literally feeds the world. Biological systems are finely tuned to use ammonia as a building block for complex mo lecule synthesis, but the use of ammonia in the laboratory is met with many obstacles ranging from the conceptual to the practical. "Ammonia is a flammable and highly corrosive gas. It also reacts readily with many common reagents and forms stable, and often inert, Werner complexes in the presence of many transition metals. These obstacles have impeded the usage of ammonia directly in synthetic methodology develop ment," said Professor Valerie A. Schmidt from the University of California, San Diego (USA). The Schmidt group consider ed that an inexpensive ammonia surrogate could be used to create new C-N bonds via alkene hydroamination.
In an effort to realize this, the authors investigated Nhydro xyphthalimide (NHPI) as a potential ammonia surro gate. "We reasoned that -if a suitable deoxygenation proced ure was identified and hydroamination occurred -the alkyl A26 Intermolecular Radical Mediated Anti-Markovnikov Alkene Hydroamination Using N-Hydroxyphthalimide J. Am. Chem. Soc. 2018, 140, 12318-12322 Literature Coverage Synform A27 phthalimide products could be hydrolyzed to the correspond ing primary amines," said Professor Schmidt. She continued: "The overall transformation achieved would be the formal addition of ammonia across a C-C double bond."
To achieve this, the group developed a dual radical atom and group transfer approach using phosphorus(III) reagents. Professor Schmidt explained: "This strategy leverages the relatively weak O-H and N-O bonds of NHPI to forge strong N-C, C-H, and phosphoranyl units. Because our dual transfer approach would generate an Ncentered, phthalimidyl radical, alkene addition should preferentially result in the formation of the anti-Markovnikov regioisomeric amine products."
Professor Schmidt concluded: "This is a userfriendly, two step procedure to access primary amines from unactivated and functionalized alkenes with a benchstable, solid ammon ia surrogate and inexpensive phosphite reagent. We are now investigating the kinetic and thermodynamic limits of this re action as well as the generality of this mechanistic approach with other functional groups." 
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Bacteria are becoming increasingly resistant to antibiotics in all parts of the world. New resistance mechanisms are emerg ing and spreading globally, thus threatening our capacity to treat even the most common infectious diseases. While bac terial infections such as pneumonia, tuberculosis and sepsis are becoming harder, and sometimes impossible, to treat as antibiotics currently in use become less effective, there is a growing need for new classes of antibiotics that can overcome resistance.
The group of Professor Ian Seiple from the University of California, San Francisco (USA) has a longstanding interest in antibiotics that inhibit protein synthesis by binding to the catal ytic center of the bacterial ribosome. These in clude many FDAapproved classes such as the streptogramins, oxazoli dinones, macrolides, lincosamides, pleuromutilins and amphenicols. "There are other classes that target the same site that show enormous potential but that have lia b ilities prevent ing their advancement as human therapies," explained Professor Seiple. He continued: "First and foremost among these classes are the lankacidins, which have attracted inter est from academia and industry for decades as a potential treatment for multidrugresistant Grampositive infections. 1 Unfortunately, this class is chemically unstable in both acidic and basic environments, greatly limiting its chemical modi fication by semisynthesis as well as its advancement to the clinic. We sought to develop a modular synthesis of lankacidin antibiotics that would allow us to develop chemically stable analogues with improved potency."
When the first report of secolankacidins appeared in the literature in January 2018, 2 the group had been working on a synthesis of the lankacidin backbone for over a year. Professor Seiple explained: "Much to our surprise, we had already pre pared a silylprotected version of 2,18secolankacidinol B en route to the cyclic members of the lankacidin class. We imme diately removed the silyl protecting groups, and we were very surprised to find that the 1 H and 13 C NMR spectra of the pro duct did not match the published spectra! Initially, we were very concerned that we had misassigned the stereochemistry of some of our intermediates, but we quickly convinced our selves by 2D NMR that our assignments were correct. Addi tionally, we noticed that no 2D NMR data was included in the publication describing the isolation, 2 and thus we assumed that they had assigned the stereochemistry by analogy to the rest of the class."
He continued: "After careful analysis, we noticed that the largest discrepancies in spectral data occurred for atoms near and around the sixmembered lactone ring, which contains two stereocenters. We then set out to synthesize all four pos sible diastereomeric combinations of these two stereocenters, with the hope that the spectra of one of these derivatives would match the spectra of the natural product."
Much to the authors' delight, the spectra of one of the four diastereomers they synthesized matched perfectly with the published data. This analogue was epimeric at the C4 position compared to the reported structure. This conclusion was sup ported by 2D NOE data, but the group sought further confirm ation by Xray crystallography. Professor Seiple remarked: "Unfortunately, we were unable to obtain Xrayquality crystals of any of the final analogues (or of derivatives there A28 Synthesis, Structural Reassignment, and Antibacterial Evaluation of 2,18-Seco-Lankacidinol B Angew. Chem. Int. Ed. 2018, 57, 13551-13554 Literature Coverage Synform A29 of). We were successful, however, in crystallizing a derivative of an intermediate that contained the full lactone core. Taken together with the other spectral data, we believe there was sufficient evidence to call for a structural reassignment of 2,18secolankacidinol B, revising the stereochemistry at C4."
In addition to reassigning the structure, the authors were interested in the antibacterial activity of acyclic members of the lankacidin class. They measured the activity of lankacidins against a panel of five Grampositive and five Gramnegative pathogens. "Perhaps unsurprisingly, the four acyclic lankaci din derivatives displayed weaktono activity against these bacteria. The lack of activity is most likely due to the absence of the macrocycle, which presumably grants a favorable con formational disposition for the binding site in the ribosome," said Professor Seiple. He continued: "It is also possible, how ever, that the lack of the pyruvamide sidechain contributes to the lack of activity, as this sidechain is present in the struc tures of all of the cyclic members."
Professor Seiple said: "This structural reassignment raises a number of questions. 2,18Secolankacidinol B is the only member of the lankacidin class that has been shown to have S stereochemistry at C4. Have any other members of the lan kacidin class been misassigned? Does the stereochemical in version offer any functional advantages to the molecule? Is it possible that the C4 stereochemistry actually exists in an S configuration during the biosynthesis for the entire class, only to be converted into R after cyclization (enzymatically or non enzymatically)? Would cyclized lankacidins with inverted C4 stereochemistry still inhibit the ribosome? Would they be more structurally stable?" Professor Seiple concluded: "We are currently pursuing the answers to these questions by developing syntheses of both natural and nonnatural lankacidins. We are excited to report the results of these studies in the near future." 
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